CAS: 226929-39-1 - LB42708
4-[[1-[[1-[(4-Bromophenyl)methyl]-1H-imidazol-5-yl]methyl]-4-(1-naphthalenyl)-1H-pyrrol-3-yl]carbonyl]morpholine
CAS:226929-39-1
Formula:
C30H27BrN4O2
Purity:
97%
Color and Shape:
Solid
Molecular weight:
555.4650
Ref: IN-DA0039B1
5mg | 342.00 € | ||
25mg | 651.00 € | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 4 Dec 2024
LB 42708
Controlled ProductCAS:226929-39-1
Applications LB 42708 is a selective nonpeptidic Farnesyltransferase (FTase) inhibitor.LB42708 suppresses tumor growth and tumor …
Formula:
C30H27BrN4O2
Color and Shape:
Neat
Molecular weight:
555.46
Ref: TR-L178790
5mg | 160.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
(1-((1-(4-Bromobenzyl)-1H-imidazol-5-yl)methyl)-4-(naphthalen-1-yl)-1H-pyrrol-3-yl)(morpholino)methanone
CAS:226929-39-1
This drug is a prodrug that is metabolized by hydrolysis to form the active metabolite, …
Formula:
C30H27BrN4O2
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
555.47 g/mol
Ref: 3D-BJA92939
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 15 Jan 2025
LB42708
CAS:226929-39-1
LB42708 is an orally active farnesyltransferase (FTase) inhibitor (IC50: 0.8/1.2/2.0 nM toward H/N/K-ras).
Formula:
C30H27BrN4O2
Purity:
97.83%
Color and Shape:
Solid
Molecular weight:
555.47
Ref: TM-T2678
1mg | 49.00 € | ||
2mg | 68.00 € | ||
5mg | 100.00 € | ||
10mg | 148.00 € | ||
25mg | 277.00 € | ||
50mg | 410.00 € | ||
100mg | 575.00 € | ||
1mL*10mM (DMSO) | 132.00 € |
Estimated delivery in United States, on Wednesday 5 Feb 2025